NRG
39
4
ROP
48
3
T
36
4
BRK.B
25
3
LB
30
11
CAG
36
2
USB
50
4
PPG
60
3
GS
58
5
KIM
60
3
MMC
50
4
AMG
52
3
GOOGL
66
2
KMX
58
6
NAVI
40
7
IFF
47
3
CINF
38
3
NDAQ
50
4
ADI
59
2
FMC
22
2
NRG
39
4
ROP
48
3
T
36
4
BRK.B
25
3
LB
30
11
CAG
36
2
USB
50
4
PPG
60
3
GS
58
5
KIM
60
3
MMC
50
4
AMG
52
3
GOOGL
66
2
KMX
58
6
NAVI
40
7
IFF
47
3
CINF
38
3
NDAQ
50
4
ADI
59
2
FMC
22
2
Financhill
Back

Nebius Group NV 10K Form

Sell
41

NBIS
Nebius Group NV

Last Price:
$27.74
Seasonality Move:
-4.07%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive NBIS News And Ratings

See the #1 stock for the next 7 days that we like better than NBIS

NBIS Financial Statistics

Sales & Book Value

Annual Sales: $9B
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $14.42
Price / Book: 1.98

Profitability

EPS (TTM): -0.63500
Net Income (TTM): $-155.5M
Gross Margin: $5B
Return on Equity: -4.57%
Return on Assets: -2.41%

Nebius Group NV Earnings Forecast

Key Nebius Group NV Financial Ratios

  • The Gross Profit Margin over the past 15 years for NBIS is 55.00%.
  • The Selling, General & Administrative Expenses for NBIS have been equal to 33.44% of Gross Profit Margin.
  • The Research & Development expenses have been 12.87% of Revenue.
  • The Interest Expense is 54.67% of Operating Income.
  • The Net Earning history of NBIS is 2.48% of Total Revenues.
  • Per Share Earnings over the last 15 years have been positive in 7 years.

Nebius Group NV Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Interactive Media & Services
Sector: Communication Services
Current Symbol: NBIS
Website: group.nebius.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 22.24
Quick Ratio: 21.85

Price-to-Earnings

Trailing P/E Ratio: 46.94
Forward P/E Ratio: 0

NBIS Technical Analysis vs Fundamental Analysis

Sell
41
Nebius Group NV (NBIS) is a Sell

Is Nebius Group NV a Buy or a Sell?

  • Nebius Group NV stock is rated a Sell
    The current Nebius Group NV [NBIS] share price is $28.25. The Score for NBIS is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.